EUVIMEDEUVIMED entdecken
Crossref

ClinBioNGS: A Clinical Bioinformatics Pipeline for Integrated Analysis of Somatic Next-Generation Sequencing Cancer Panels

Raúl Marín iD, Ania Alay iD, Maria Ajenjo-Bauza, Sara Hijazo-Pechero iD, Carla Montironi, Eva Hernández-Illán, Pedro Jares, Daniel Azuara, Mar Varela iD, August Vidal, Joan Anton Puig-Butillé, Conxi Lázaro iD und 4 weitere

JCO Clinical Cancer Informatics · 2026

DOI: 10.1200/cci-25-00221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2026. Verfasst von Raúl Marín und 15 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Bioinformatics for Precision Oncology (UBOP), Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Computational Biology, Neoplasms, Software. Die Arbeit nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Somatic next-generation sequencing (NGS) panels are widely used in precision oncology to detect clinically actionable genomic alterations. However, interpreting diverse DNA and RNA alterations remains challenging because of the complexity of tumor-only data and the limitations of current pipelines, which are often proprietary, noncustomizable, or lack visual reports to support clinical interpretation. We present ClinBioNGS, an open-source, panel-agnostic bioinformatics pipeline for the comprehensive analysis of somatic NGS cancer panels in both clinical and translational settings. MATERIALS AND METHODS ClinBioNGS is a modular, fully containerized workflow implemented in Nextflow. It supports integrated analysis of DNA and RNA data, including multicaller small variant detection, copy number alteration (CNA) profiling, gene fusion and splice variant identification, and evaluation of complex genomic biomarkers such as tumor mutational burden and microsatellite instability. Variants are annotated and prioritized using established clinical frameworks. The results are compiled in a self-contained interactive HTML report with dynamic tables and informative visualizations to facilitate clinical interpretation. Validation included SEQC2 reference data sets across six commercial panels, and benchmarking was performed on 2,024 clinical tumor samples analyzed with three commercial platforms. RESULTS ClinBioNGS achieved high accuracy in SEQC2 validation, with precision (0.987-1.000), recall (0.920-0.997), and F1 scores (0.956-0.999) across diverse panels. In a clinical benchmarking with real-world data, the pipeline demonstrated high concordance with commercial solutions for small variants (97%), CNAs (89%), and RNA alterations (94%), while also identifying additional high-confidence alterations missed by vendor pipelines. CONCLUSION ClinBioNGS provides a robust, flexible, and transparent solution for standardized analysis of somatic NGS cancer panels. It supports reproducible, clinically oriented interpretation of genomic data and is freely available for noncommercial research-use only at GitHub.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingComputational BiologyNeoplasmsSoftwareHumansGenomicsBiomarkers, TumorDNA Copy Number VariationsMutation

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Unit of Bioinformatics for Precision Oncology (UBOP), Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Preclinical and Experimental Research in Thoracic Tumors (PRETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de L…
  • PhD Program in Bioinformatics, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut Català d'Oncologia (ICO), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet del Llob…
  • Molecular Biology CORE. Center for Biomedical Diagnostics (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Pathology Department, Center for Biomedical Diagnostics (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.

ORCID-Profile: Raúl Marín, Ania Alay, Sara Hijazo-Pechero, Mar Varela, Conxi Lázaro, Víctor Moreno, David Cordero, Ernest Nadal, Xavier Solé

Zitieren

APA

Marín, R., Alay, A., Ajenjo-Bauza, M., Hijazo-Pechero, S., Montironi, C., Hernández-Illán, E., Jares, P., Azuara, D., Varela, M., Vidal, A., Puig-Butillé, J. A., Lázaro, C., Moreno, V., Cordero, D., Nadal, E., & Solé, X. (2026). ClinBioNGS: A Clinical Bioinformatics Pipeline for Integrated Analysis of Somatic Next-Generation Sequencing Cancer Panels. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-25-00221

Vancouver

Marín R, Alay A, Ajenjo-Bauza M, Hijazo-Pechero S, Montironi C, Hernández-Illán E, et al. ClinBioNGS: A Clinical Bioinformatics Pipeline for Integrated Analysis of Somatic Next-Generation Sequencing Cancer Panels. JCO Clinical Cancer Informatics. 2026. doi:10.1200/cci-25-00221

BibTeX
@article{Marn2026,
  author = {Marín, Raúl and Alay, Ania and Ajenjo-Bauza, Maria and Hijazo-Pechero, Sara and Montironi, Carla and Hernández-Illán, Eva and Jares, Pedro and Azuara, Daniel and Varela, Mar and Vidal, August and Puig-Butillé, Joan Anton and Lázaro, Conxi and Moreno, Víctor and Cordero, David and Nadal, Ernest and Solé, Xavier},
  title = {ClinBioNGS: A Clinical Bioinformatics Pipeline for Integrated Analysis of Somatic Next-Generation Sequencing Cancer Panels},
  journal = {JCO Clinical Cancer Informatics},
  year = {2026},
  doi = {10.1200/cci-25-00221}
}
Kostenlos starten →